A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients

Clinical trial NCT06021860 · UNKNOWN

Trial details

NCT number: NCT06021860
Sponsor: CMP Development, LLC
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Edema Due to Heart Failure or Cirrhosis

Start date: 2024-06-01
Primary completion: 2025-03-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.